RDIF calls on Italian-Swiss contacts to secure Sputnik V production

Head of the Russian Direct Investment Fund Kirill Dmitriev.
Head of the Russian Direct Investment Fund Kirill Dmitriev. © Reuters
While the European Union is still divided over Russia's Sputnik V vaccine, Moscow's sovereign wealth fund is working its contacts with European pharmaceutical groups, starting with Antonio di Naro's Swiss group Adienne, with the view towards future production. [...] (439 words)
Issue dated 28/04/2021 Reading time 2 minutes

Read this article here:

This article may be accessed by subscribers and e-wallet holders (USD 12.50)
Log in to read more

Subscribe or Pay-Per-Article
Discover our offers
Further reading
On our other sites

New: Sign up for real-time alerts and be notified of new editions!  

Once registered, you will be notified by a short message on your computer or mobile phone as soon as a new edition of our publication or an alert is published. Stay informed anytime, anywhere!